Chorda Pharma, Inc. — Form D/A
Chorda Pharma, Inc. of ROANOKE, VA, a company, filed a Form D amendment with the SEC on 2022-04-26. The offering totals $500K, of which $293K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2022-04-26
- Form: D/A
- Accession: 0001906254-22-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $500K
- Amount sold: $293K
- Remaining: $208K
- Minimum investment: $5K
- Investors: 13
- Date of first sale: 2021-12-17
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-431676
Issuer
- Name: Chorda Pharma, Inc.
- CIK: 0001906254
- Entity type: Corporation
- Jurisdiction: VIRGINIA
- Incorporated: 2018
- Address: 709 S JEFFERSON STREET, ROANOKE, VA, 24016
- Phone: 5406320679
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Troy Keyser | Director | Roanoke, VA |
| Robert Vaughn | Director | Roanoke, VA |
| George Robert Vaughan, Jr. | Director | Roanoke, VA |
| Aileen B Helsel | Director | Roanoke, VA |
| Richard Carliss | Director | Roanoke, VA |
| Richard Carliss | Executive Officer | Roanoke, VA |
| Richard Carliss | Promoter | Roanoke, VA |
| John B Williamson III | Director | Roanoke, VA |
| Victor Iannello | Director | Roanoke, VA |
| Victor Iannello | Executive Officer | Roanoke, VA |
| Victor Iannello | Promoter | Roanoke, VA |
Other filings by this issuer (2)
More